Sudbury, MA -- January 11, 2022 - FluidForm, a leader in the field of recreating human tissue to radically transform drug discovery, surgical repair, and replacement, today announced an investment from Hackensack Meridian Health and its Bear’s Den innovation program. The investment will enable FluidForm to advance key applications in tissue for drug discovery and surgical repair, including collaboration on preclinical work in 2022

FluidForm, a leader in the field of human tissue for research, repair, and replacement, signed an agreement with Ethicon, Inc., a member of the Johnson & Johnson Medical Devices Companies, to develop 3D Bioprinted applications using FluidForm’s patented FRESH technology.